Chemical and biological strategies for engineering cell surface glycosylation

Annual Review of Cell and Developmental Biology

Volumn 17, Issue , 2001, Pages 1-23

  Saxon, E ^a   Bertozzi, C R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glycobiology; Glycolipid; Glycoprotein; Glycosyltransferase inhibitor; Unnatural carbohydrate

Indexed keywords

CARBOHYDRATE; CELL PROTEIN; GLYCOSIDASE; GLYCOSYLTRANSFERASE INHIBITOR; OLIGOSACCHARIDE;

BIOENGINEERING; CARBOHYDRATE SYNTHESIS; CELL ADHESION; CELL SURFACE; CONFERENCE PAPER; ENZYME ACTIVITY; GLYCOSYLATION; HUMAN; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; SIGNAL TRANSDUCTION;

ANIMALS; CELL ADHESION; CELL LINE; CELL MEMBRANE; EPITOPES; GLYCOCONJUGATES; GLYCOSIDE HYDROLASES; GLYCOSYLATION; GLYCOSYLTRANSFERASES; HUMANS; MICE; MICE, TRANSGENIC; OLIGOSACCHARIDES; PROTEIN ENGINEERING; PROTEIN FOLDING;

EID: 0035179085     PISSN: 10810706     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.cellbio.17.1.1     Document Type: Conference Paper

References (91)

1. Cell surface sialic acid and the regulation of immune cell interactions: The neuraminidase effect reconsidered
2. Modification on CD43 and other lymphocyte O-glycoproteins by core 2 N-acetylglucosaminyltransferase
3. Glycosyltransferase activity of Fringe modulates Notch-Delta interactions
4. Inhibition of mucin synthesis by benzyl αGalNAc in KATO III gastric cancer and Caco-2 colon cancer cells
5. Conversion of cellular sialic acid expression from N-acetyl- to N-glycolylneuraminic acid using a synthetic precursor, N-glycolylmannosamine pentaacetate: Inhibition of myelin-associated glycoprotein binding to neural cells
6. O-glycosylation of nuclear and cytosolic proteins
7. Glycobiology of the cell surface: The emergence of sugars as an important feature of the cell periphery
8. Protein glycosylation in development and disease
9. Acceptor specificity of GDP-Fuc:Galβ14GlcNAc-R α3-fucosyltransferase VI (FucTVI) expressed in insect cells as a soluble, secreted enzyme
10. Glycobiology - Toward understanding the function of sugars
11. A potent oligosaccharyl transferase inhibitor that crosses the intracellular endoplasmic reticulum membrane
12. Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains
13. Glycosidase inhibitors: Inhibitors of N-linked oligosaccharide processing
14. Substrate and donor specificity of glycosyl transferases
15. α-Galactosyl (Gala 1-3Galβ1-4GlcNAc-R) epitopes on human cells: Synthesis of the epitope on human red cells by recombinant primate α1,3 galactosyltransferase expressed in E. coli
16. Expression of a specific glycosyltransferase enzyme regulates T cell death mediated by galectin-1
17. Metabolic substrate engineering as a tool for glycobiology
18. Enzymatic transfer of sialic acids modified at C-5 employing four different sialyltransferases
19. Ketone isosteres of 2-N-acetamidosugars as substrates for metabolic cell surface engineering
20. Methyl 3-amino 3-deoxy-β-D-galactopyranosyl-(1-4)-2-ace tamido-2-deoxy-β-D-glucopyranoside: An inhibitor of UDP-D-galactose:-β-D-galactopyranosyl-(1-4)-2-acetamido-2-deoxy- Dglucose(1-3)-α-D-galactopyranosyltransferase
21. Immune regulation by the ST6Gal sialyltransferase
22. The remodeling of glycoconjugates in mice
23. Effect of benzyl-α-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells
24. P-selectin glycoprotein ligand- 1 and E-selectin ligand-1 are differentially modified by fucosyltransferases Fuc-TIV and Fuc-TVII in mouse neutrophils
25. Conformational implications of asparagine-linked glycosylation
26. Metabolic labeling of glycoproteins with chemical tags through unnatural sialic acid biosynthesis
27. Biosynthesis of nonphysiological sialic acid in different rat organs, using N-propanoyl-D-hexosamines as precursors
28. Structural and functional analysis of peptidyl oligosaccharyl transferase inhibitors
29. Functional groups of sialic acids involved in binding to siglecs (sialoadhesins) deduced from interactions with synthetic analogues
30. Elongation of the N-acyl side chain of sialic acids in MDCK II cells inhibits influenza A virus infection
31. UDP-GlcNAc 2-epimerase: A regulator of cell surface sialylation
32. Biosynthetic modulation of sialic acid-dependent virus-receptor interactions of two primate polyoma viruses
33. Influenza virus sialidase: A target for drug discovery
34. Synthesis of complex carbohydrates and glycoconjugates: Enzyme-based and programmable one-pot strategies
35. Reduction of the major xenoantigen on glycosphingolipids of swine endothelial cells by various glycosyltransferases
36. Assembly of asparagine-linked oligosaccharides
37. Intracellular inhibition of blood group A glycosyltransferase
38. Synthesis of α-galactosyl epitopes by recombinant α1,3galactosyltransferase for opsonization of human tumor cell vaccines by anti-galactose
39. Study of the enzymatic transformation of fluorescently labeled oligosaccharides in human epidermoid cells using capillary electrophoresis with laser-induced fluorescence detection
40. Engineering novel cell surface receptors for virus-mediated gene transfer
41. Chemoselective ligation reactions with proteins, oligosaccharides and cells
42. Modulating cell surface immunoreactivity by metabolic induction of unnatural carbohydrate antigens
43. Exploiting differences in sialoside expression for selective targeting of MRI contrast reagents
44. Discovery and development of GS 4104 (oseltamivir): An orally active influenza neuraminidase inhibitor
45. Selection and characterization of a neuraminidase-minus mutant of influenza virus and its rescue by cloned neuraminidase genes
46. Biochemical engineering of surface α2-8 polysilic acid for immuntargeting tumor cells
47. ELAM-1dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA
48. Synthesis and evaluation of eight aminodeoxy trisaccharide inhibitors for N-acetylglucosaminyltransferase-V
49. Engineered cell surfaces: Fertile ground for molecular landscaping
50. Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis
51. The alpha(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis
52. Exploring the glycan repertoire of genetically modified mice by isolation and profiling of the major glycan classes and nano-NMR analysis of glycan mixtures
53. Will the transgenic mouse serve as a Rosetta Stone to glycoconjugate function?
54. Complexity in O-linked oligosaccharide biosynthesis engendered by multiple polypeptide N-acetylgalactosaminyltransferases
55. Heparan sulfate primed on β-D-xylosides restores binding of basic fibroblast growth factor
56. Fringe is a glycosyltransferase that modifies Notch
57. The notch signalling regulator fringe acts in the golgi apparatus and requires the glycosyltransferase signature motif DxD
58. Mammalian GPI proteins: Sorting, membrane residence and functions
59. α(1,3)Fucosyltransferases expressed by the gain-of-function Chinese hamster ovary glycosylation mutants LEC12, LEC29, and LEC30
60. Automated solid-phase synthesis of oligosaccharides
61. A Schiff base with mildly oxidized carbohydrate ligands stabilizes L-selectin and not P-selectin or E-selectin rolling adhesions in shear flow
62. Synergistic inhibition of human α-1,3-fucosyltransferase V
63. 3 inhibition of EGF receptor mediated signal transduction
64. Endothelial ligands for L-selectin
65. Leukocyte adhesion-two selectins converge on sulphate
66. Glycosylation: Heterogeneity and the 3D structure of proteins
67. Rapid, sensitive sequencing of oligosaccharides from glycoproteins
68. Roles for glycosylation of cell surface receptors in cellular immune recognition
69. x by acetylated Galβ1-4GlcNAcβ-O-naphthalenemethanol
70. x inhibit selectin-mediated cell adhesion
71. Cell surface engineering by a modified staudinger reaction
72. Sialyl-transferase inhibitors based on CMP-quinic acid
73. Biochemical engineering of neural cell surfaces by the synthetic N-propanoyl-substituted neuraminic acid precursor
74. Donor substrate specificity of recombinant human blood group A, B and hybrid A/B glycosyltransferases expressed in Escherichia coli
75. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny
76. Enzymatic transfer of a pre-assembled trisaccharide antigen to cell surfaces using a fucosyltransferase
77. Glycosyltransferase mutants: Key to new insights in glycobiology
78. CHO cells provide access to novel Nglycans and developmentally regulated glycosyltransferases
79. LEC 14, a dominant CHO glycosylation mutant expresses complex N-glycans with a new N-acetylglucosamine residue in the core region
80. Differential immune responses to αGal epitopes on xenografts and allografts: Implications for accommodation in xenotransplantation
81. α-1,3-Galactosyltransferase-deficient mice produce naturally occurring cytotoxic anti-Gal antibodies
82. x expressed on the cell surface supports L-selectin mediated adhesion
83. x tetrasaccharide transferred on the cell surface
84. Probing the extended binding determinants of oligosaccharyl transferase with synthetic inhibitors of asparagine-linked glycosylation
85. Concepts and principles of O-linked glycosylation
86. Biological roles of oligosaccharides: All of the theories are correct
87. Sequencing complex polysaccharides
88. Specialized contributions by α(1,3)-fucosyltransferase-IV and FucT-VII during leukocyte rolling in dermal microvessels
89. In vivo modulated N-acyl side chain of N-acetylneuraminic acid modulates the cell contact dependent inhibition of growth
90. Glycoproteins: Glycan presentation and protein-fold stability
91. Metabolic delivery of ketone groups to sialic acid residues - Application to cell surface glycoform engineering